Clinical Trials Disrupted During War in Ukraine, Clinical Trials in Ukraine
Clinical Trials Disrupted During War in Ukraine Ukraine is recognized as an attractive location for conducting clinical trials. In April there were listed nearly 400 studies in Ukraine by ClinicalTrials.gov. However, due to the continuing war in Ukraine and the sanctions against Russia drug manufacturers had to stop recruiting patients to existing trials and put the launch of new trials on hold.
clinical trials in central & easter europe, Meet Cromos Pharma at SCOPE 2022,
Key takeaways from Scope 2022 Cromos Pharma kicked off the event trail in February by participating in SCOPE 2022 in Orlando, Florida. Nicole Brenna, US Business Development Director, represented Cromos Pharma at the event which was well attended by vendors and Sponsors.  Following COVID protocols including mask-wearing, testing on site, and sanitizers, delegates were glad to be getting the chance to
The role of decentralized approaches in clinical trials, clinical trials phases
The role of decentralized approaches in clinical trials Decentralized approaches to clinical trials have been cited as a key trend in the industry for many years. However, the COVID-19 pandemic resulted in a rapid acceleration of the trend. A recent report by Clinical Trials Arena using data analysis by GlobalData[1] found that a “record number of around 1,300 trials with a decentralised and/or

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us